Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin L Ebert

Showing results (21-30 of 339) with videos related to

Pageof 34
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 12, 2012
Janus reveals another face: the biologic rationale for targeting Janus kinase 2 in lymphomaAnn Mullally, Benjamin L Ebert
Blood|October 7, 2015
The novel mechanism of lenalidomide activityEmma C Fink, Benjamin L Ebert
The New England Journal of Medicine|April 23, 2025
Clonal Hematopoiesis as a Driver of Solid TumorsLachelle D Weeks, Benjamin L Ebert
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2017
Clinical Implications of Genetic Mutations in Myelodysplastic SyndromeJames A Kennedy, Benjamin L Ebert
Expert Review of Hematology|July 12, 2012
Novel approaches to the treatment of sickle cell disease: the potential of histone deacetylase inhibitorsMaureen M Okam, Benjamin L Ebert
Cancer Cell|May 13, 2015
Charting the "Splice" Routes to MDSEsther A Obeng, Benjamin L Ebert
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2017
Introduction to Genomics in Hematologic MalignancyBenjamin L Ebert, Jonathan W Friedberg
Blood|May 25, 2004
Genomic approaches to hematologic malignanciesBenjamin L Ebert, Todd R Golub
Blood|October 20, 2022
Clonal hematopoiesis transcending species barriersPhilipp J Rauch, Benjamin L Ebert
Blood|May 25, 2013
Initial experience with L-leucine therapy in myelodysplastic syndromes with associated chromosome 5q deletionDavid P Steensma, Benjamin L Ebert
Pageof 34

Showing results (21-30 of 339) with videos related to

Sort By:
Pageof 34
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 12, 2012
Janus reveals another face: the biologic rationale for targeting Janus kinase 2 in lymphomaAnn Mullally, Benjamin L Ebert
Blood|October 7, 2015
The novel mechanism of lenalidomide activityEmma C Fink, Benjamin L Ebert
The New England Journal of Medicine|April 23, 2025
Clonal Hematopoiesis as a Driver of Solid TumorsLachelle D Weeks, Benjamin L Ebert
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2017
Clinical Implications of Genetic Mutations in Myelodysplastic SyndromeJames A Kennedy, Benjamin L Ebert
Expert Review of Hematology|July 12, 2012
Novel approaches to the treatment of sickle cell disease: the potential of histone deacetylase inhibitorsMaureen M Okam, Benjamin L Ebert
Cancer Cell|May 13, 2015
Charting the "Splice" Routes to MDSEsther A Obeng, Benjamin L Ebert
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2017
Introduction to Genomics in Hematologic MalignancyBenjamin L Ebert, Jonathan W Friedberg
Blood|May 25, 2004
Genomic approaches to hematologic malignanciesBenjamin L Ebert, Todd R Golub
Blood|October 20, 2022
Clonal hematopoiesis transcending species barriersPhilipp J Rauch, Benjamin L Ebert
Blood|May 25, 2013
Initial experience with L-leucine therapy in myelodysplastic syndromes with associated chromosome 5q deletionDavid P Steensma, Benjamin L Ebert
Pageof 34